Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Inventory (2021 - 2025)

Macrogenics (MGNX) has disclosed Inventory for 5 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory changed N/A to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a N/A change, with the full-year FY2025 number at $7.9 million, changed N/A from a year prior.
  • Inventory was $7.9 million for Q4 2025 at Macrogenics, down from $8.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $9.4 million in Q1 2025 to a low of $1.1 million in Q3 2023.
  • A 5-year average of $4.1 million and a median of $3.2 million in 2024 define the central range for Inventory.
  • Peak YoY movement for Inventory: plummeted 72.71% in 2022, then surged 734.08% in 2025.
  • Macrogenics' Inventory stood at $4.4 million in 2021, then crashed by 66.93% to $1.5 million in 2022, then dropped by 15.85% to $1.2 million in 2023, then skyrocketed by 165.68% to $3.2 million in 2024, then skyrocketed by 143.83% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Inventory are $7.9 million (Q4 2025), $8.8 million (Q3 2025), and $9.3 million (Q2 2025).